These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31806623)

  • 1. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.
    Liu B; Hood JD; Kolawole EM; Woodruff DM; Vignali DA; Bettini M; Evavold BD
    Diabetes; 2020 Mar; 69(3):381-391. PubMed ID: 31806623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
    Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
    J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice.
    Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B
    Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
    Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
    Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
    You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
    J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.
    Jin N; Wang Y; Crawford F; White J; Marrack P; Dai S; Kappler JW
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13318-23. PubMed ID: 26453556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
    Parras D; Solé P; Delong T; Santamaría P; Serra P
    Front Immunol; 2021; 12():737428. PubMed ID: 34527002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
    Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
    J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
    Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
    Front Immunol; 2021; 12():668680. PubMed ID: 34113344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential.
    Bettini M; Blanchfield L; Castellaw A; Zhang Q; Nakayama M; Smeltzer MP; Zhang H; Hogquist KA; Evavold BD; Vignali DA
    J Immunol; 2014 Jul; 193(2):571-9. PubMed ID: 24943217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.
    Delong T; Baker RL; He J; Barbour G; Bradley B; Haskins K
    Diabetes; 2012 Dec; 61(12):3239-46. PubMed ID: 22912420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody with broad specificity for the ligands of insulin B:9-23 reactive T cells prevents spontaneous type 1 diabetes in mice.
    Cepeda JR; Sekhar NS; Han J; Xiong W; Zhang N; Yu L; Dai S; Davidson HW; Kappler JW; An Z; Zhang L
    MAbs; 2020; 12(1):1836714. PubMed ID: 33151102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A is an autoantigen in type 1 diabetes.
    Stadinski BD; Delong T; Reisdorph N; Reisdorph R; Powell RL; Armstrong M; Piganelli JD; Barbour G; Bradley B; Crawford F; Marrack P; Mahata SK; Kappler JW; Haskins K
    Nat Immunol; 2010 Mar; 11(3):225-31. PubMed ID: 20139986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A Deficiency Confers Protection From Autoimmune Diabetes via Multiple Mechanisms.
    Srivastava N; Hu H; Vomund AN; Peterson OJ; Baker RL; Haskins K; Teyton L; Wan X; Unanue ER
    Diabetes; 2021 Dec; 70(12):2860-2870. PubMed ID: 34497137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
    Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
    J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.